# Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest

> **NCT03640949** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lars Wiuff Andersen** · enrollment: 501 (actual)

## Conditions studied

- Heart Arrest

## Interventions

- **DRUG:** Vasopressin, Arginine
- **DRUG:** Methylprednisolone
- **DRUG:** NaCl

## Key facts

- **NCT ID:** NCT03640949
- **Lead sponsor:** Lars Wiuff Andersen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2021-01-21
- **Final completion:** 2022-01-21
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640949, "Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03640949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*